SHF Holdings, Inc.
For the period ended Dec 31, 2025. Filed Apr 15, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 15, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31,2025 OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _________to _________
Commission File Number 001-40524
SHF Holdings, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | 86-2409612 |
|---|---|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification Number) |
| 1526 Cole Blvd., Suite 250 Golden, Colorado | 80401 |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:(303) 431-3435
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Class A Common Stock, $0.0001 par value per share | SHFS | The Nasdaq Stock Market LLC |
| Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $230 per share | SHFSW | The Nasdaq Stock Market LLC |
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ | ||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No☒
The aggregate market value of the Class A Common Stock held by non-affiliates of the registrant, based on the closing price of a share of the registrant’s Common Stock on June 30, 2025 as reported by The Nasdaq Capital Market on such date, was approximately $3.1 million.
As of April 10, 2026, there were 4,505,486 shares of the Company’s Class A Common Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive proxy statement pursuant to Regulation 14A for the registrant’s 2026 Annual Meeting of Shareholders, to be filed within 120 days of the registrant’s fiscal year end, are incorporated by reference into Part III hereof.
SHF HOLDINGS, INC.
FORM 10-K
December 31, 2025
TABLE OF CONTENTS
| Page | ||
|---|---|---|
| PART I | ||
| Item 1. | Business | 7 |
| Item 1A. | Risk Factors | 22 |
| Item 1B. | Unresolved Staff Comments | 32 |
| Item 1C. | Cybersecurity | 32 |
| Item 2. | Properties | 34 |
| Item 3. | Legal Proceedings | 34 |
| Item 4. | Mine Safety Disclosures | 34 |
| PART II | ||
| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 35 |
| Item 6. | [Reserved] | 35 |
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 36 |
| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk | 56 |
| Item 8. | Financial Statements and Supplementary Data | 56 |
| Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure | 56 |
| Item 9A. | Controls and Procedures | 56 |
| Item 9B. | Other Information | 58 |
| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 58 |
| PART III | ||
| Item 10. | Directors, Executive Officers and Corporate Governance | 59 |
| Item 11. | Executive Compensation | 60 |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 65 |
| Item 13. | Certain Relationships and Related Transactions, and Director Independence | 66 |
| Item 14. | Principal Accountant Fees and Services | 67 |
| PART IV | ||
| Item 15. | Exhibit and Financial Statement Schedules | 68 |
| Signatures | 72 | |
USE OF MARKET AND INDUSTRY DATA
This Annual Report on Form 10-K (this “Annual Report on Form 10-K” or “Form 10-K” includes market and industry data that we have obtained from third-party sources, including, without limitation industry publications, as well as industry data prepared by our management on the basis of its knowledge of and experience in the industries in which we operate (including our management’s estimates and assumptions relating to such industries based on that knowledge). Management has developed its knowledge of such industries through its experience and participation in these industries. While our management believes the third-party sources referred to in this Annual Report on Form 10-K are reliable as of the date hereof, neither we nor our management have independently verified any of the data from such sources referred to in this Annual Report on Form 10-K or ascertained the underlying economic assumptions relied upon by such sources and therefore cannot guarantee that such information is accurate or complete. Furthermore, internally prepared and third-party market prospective information, in particular, are estimates only and there may be differences between the prospective and actual results because events and circumstances may not occur as expected, and those differences may be material. Also, references in this Annual Report on Form 10-K to any publications, reports, surveys or articles prepared by third parties should not be construed as depicting the complete findings of the entire publication, reports, surveys or articles. The information in any such publication, report, survey or article is not incorporated by reference in this Annual Report on Form 10-K.
TRADEMARKS, TRADE NAMES AND SERVICE MARKS
“SHF Holdings”, “Safe Harbor,” “Safe Harbor Financial,” and other trademarks or service marks of SHF Holdings, Inc. (the “Company”) appearing in this Annual Report on Form 10-K are the property of the Company. The other trademarks, trade names and service marks appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report on Form 10-K are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.
OTHER PERTINENT INFORMATION
Unless the context otherwise indicates, when used in this Annual Report on Form 10-K, the terms “SHF Holdings,” “Safe Harbor,” “we,” “us,” “our,” the “Company” and similar terms refer to the Company, a Delaware corporation and its wholly-owned subsidiaries, SHF, LLC, SHFxAbaca, LLC, Safe Harbor Retirement Services, LLC and SHF Managed Services, LLC.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Various statements made in this Form 10-K are “forward-looking statements” within the meaning of, and subject to the protections of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements with respect to the Company’s beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance and condition, and involve known and unknown risks, uncertainties and other factors, which may be beyond the Company’s control, and which may cause the actual results, performance, achievements, or financial condition of the Company to be materially different from future results, performance, achievements, or financial condition expressed or implied by such forward-looking statements. Furthermore, this Form 10-K may contain forward-looking statements regarding the potential for federal rescheduling of cannabis, the potential passage of the SAFER Banking Act of 2025 (the “SAFER Banking Act”), projected growth of the cannabis market, the potential impact of regulatory changes on the Company’s business, and the anticipated benefits of the Second Amended and Restated Commercial Alliance Agreement (the “Second Amended CAA”). You should not expect us to update any forward-looking statements. These forward-looking statements should be read together with the discussion of the Company’s risks and uncertainties included in Part I, Item 1A., “Risk Factors” beginning on page 24 of this Form 10-K.
All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as “may,” “will,” “anticipate,” “assume,” “seek,” “should,” “indicate,” “would,” “believe,” “contemplate,” “consider,” “expect,” “estimate,” “continue,” “plan,” “point to,” “project,” “could,” “intend,” “target” and other similar words and expressions of the future. These forward-looking statements may not be realized due to a variety of factors, including, without limitation:
Our profitability is subject to interest rate risk;
Volatility and uncertainty in the financial markets and banking industry may adversely impact our clients and our ability to obtain additional financial institution customers;
Liquidity risks could affect our operations and jeopardize our financial condition and certain funding sources could increase our interest rate expense;
The industry in which our clients operate is considered federally illegal, which may pose risk if actions were taken against those clients or our Company;
Our strategic plan and growth strategy may not be achieved as quickly or as fully as we seek;
Our success depends on our ability to compete effectively in highly competitive markets;
Potential gaps in our risk management policies may leave us exposed to unidentified or unanticipated risk, which could negatively affect our business;
Our ability to resolve our material weaknesses in internal controls over financial reporting;
We have identified and we may identify additional deficiencies in our internal controls, which may have an impact on our business operations;
Technological changes affect our business including potentially impacting the revenue stream of traditional products and services, and we may have fewer resources than many competitors to invest in technological improvements;
Our information systems may experience interruptions and security breaches, and are exposed to cybersecurity threats;
Many of our major systems depend on and are operated by third-party vendors, and any systems failures or interruptions could adversely affect our operations and the services we provide to our clients;
Any failure to protect the confidentiality of customer information could adversely affect our reputation and subject us to financial sanctions and other costs that could have a material adverse effect on our business, financial condition and results of operations;
Future acquisitions and expansion activities may disrupt our business, dilute shareholder value and adversely affect our operating results;
We may not be able to generate sufficient cash to service all of our operation needs, including our debt obligations;
We may incur a substantial level of debt that could materially adversely affect our ability to generate sufficient cash to fulfill our obligations;
Our business may be adversely affected by economic conditions in general and by conditions in the financial markets;
We are subject to extensive regulations that could limit or restrict our activities and adversely affect our earnings;
Litigation and regulatory investigations are increasingly common in our businesses and may result in significant financial losses and/or harm to our reputation;
Liquidity risks arising from the uncertainty surrounding cash flows;
We are subject to capital adequacy and Nasdaq liquidity standards, and if we fail to meet these standards, whether due to losses, growth opportunities or an inability to raise additional capital or otherwise, our financial condition and results of operations would be adversely affected;
Certain of our existing stockholders could exert significant control over the Company;
If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the price of our Common Stock and its trading volume could decline;
We have the ability to issue additional equity securities, which would lead to dilution of our issued and outstanding Common Stock;
We are an “emerging growth company,” and, as a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our Common Stock may be less attractive to investors;
We may be unable to attract and retain key people to support our business;
In certain circumstances, we assume the risk of fraud loss and negative balances for accounts maintained at our financial institution partners;
Severe weather, natural disasters, global pandemics, acts of war or terrorism, theft, civil unrest, government expropriation or other external events could have significant effects on our business;
There is substantial doubt about our ability to continue as a going concern;
The Company’s ability to comply with Nasdaq, Nasdaq’s listing requirements and maintain its listing on Nasdaq is uncertain and subject to various risks and factors that may cause actual results to differ materially; and
Other factors and information in other filings that we make with the Securities and Exchange Commission (the “SEC”) under the Exchange Act and Securities Act.
The foregoing factors should not be construed as exhaustive and should be read together with the other cautionary statements included in this Form 10-K. Because of these risks and other uncertainties, our actual future financial condition, results, performance or achievements, or industry results, may be materially different from the results indicated by the forward-looking statements in this Form 10-K. In addition, our past results of operations are not necessarily indicative of our future results of operations. You should not rely on any forward-looking statements as predictions of future events.
All written or oral forward-looking statements that are made by us or are attributable to us are expressly qualified in their entirety by this cautionary note. Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update, revise or correct any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.
SUMMARY OF RISK FACTORS
Our business is subject to a number of risks, which are discussed more fully in Part I, Item 1A. “Risk Factors” beginning on page 24 of this Annual Report, that could cause actual results to differ materially from those indicated by forward-looking statements made in this Annual Report or presented elsewhere from time to time. Capitalized terms used but not otherwise defined in the following summary have the meanings ascribed to them elsewhere in this Annual Report on Form 10-K. These risks include, but are not limited to, the following:
Risks Related to the Company’s Business
| ● | Our revenue has declined significantly in recent periods, and we cannot guarantee that the economics of the Second Amended CAA will fully restore our financial performance. |
| ● | Our revenue has declined due to account attrition, lower pricing, introduction of money market accounts that share interest earned with the depositor and reduced transaction activity within the cannabis industry. |
| ● | Volatility in interest rates may adversely affect our revenues, profitability, and competitive position. |
| ● | Our recurring operating losses and negative cash flows from operations raise substantial doubt about our ability to continue as a going concern. |
Risks Related to the Second Amended CAA
| ● | PCCU’s loan program is substantially dependent on the regulatory restrictions placed on PCCU, which may limit the types, terms, and amounts of loans offered. |
| ● | The Second Amended CAA reinstates an indemnification obligation of up to 65% of loan loss. |
| ● | We are required to maintain sufficient balance sheet resources to support our indemnification obligations under the Second Amended CAA. |
| ● | Our indemnification obligation is unlimited in amount, and our actual losses could exceed our current estimates and our available cash. |
| ● | We are required to maintain sufficient cash and cash equivalents to support our indemnification obligations under the Second Amended CAA. |
| ● | PCCU retains final loan approval authority and may decline loans that meet our underwriting standards, which could limit our revenue growth. |
| ● | One borrower represents approximately 18% of the total loan portfolio and carries the second highest risk classification. |
| ● | The CRB loan portfolio is concentrated entirely in the cannabis industry, and cannabis-specific collateral is subject to significant valuation discounts, legal uncertainties, and a limited buyer pool in a foreclosure or forced sale. |
| ● | Certain provisions in the Second Amended CAA create a direct link between our listing compliance and our revenue. |
| ● | The initial fair value measurement of our stand-ready guarantee liability at inception under the Second Amended CAA involves significant estimates and judgment and is subject to material uncertainty. |
| ● | Our ongoing expected financial indemnification liability under the CECL standard (ASC 326) requires quarterly ongoing remeasurement and is subject to material uncertainty. |
| ● | We are dependent on third parties, including PCCU and other service providers, for certain critical services and disruptions at PCCU would directly and immediately impair our operations. |
| ● | Loan program income (formerly loan interest income) could decline under the Second Amended CAA if the indemnity reserve would cause our shareholders’ equity to drop below the Nasdaq Listing Requirements to maintain compliance. |
Risks Related to the Cannabis Industry and Regulatory Environment
| ● | We have agreements with financial institutions that provide banking services to CRBs, which exposes us to additional liabilities, regulatory compliance costs, and reputational risk. |
| ● | Cannabis remains a Schedule I controlled substance under federal law and changes in federal enforcement policy or the scheduling status of cannabis could affect our business in unpredictable ways. |
| ● | The Company, our financial institution customers, and our CRB clients are subject to complex federal and state laws governing financial transactions related to cannabis, which could subject them to legal claims or restrict their activities. |
| ● | State-level regulatory changes including market saturation, license non-renewals, and changes to cannabis program structures could impair borrower viability and increase the credit risk in the portfolio we indemnify. |
| ● | Because cannabis remains federally illegal, CRB borrowers generally cannot access bankruptcy protections but instead work through the receivership process, which complicates loan workouts and could increase our loss given default. |
| ● | Service providers to cannabis businesses may be subject to unfavorable U.S. federal income tax treatment, including potential disallowance of ordinary business deductions under Section 280E. |
| ● | Cannabis businesses may be subject to civil asset forfeiture under federal law, which could result in the loss of collateral securing loans in our portfolio. |
| ● | We may have difficulty enforcing certain of our commercial agreements and contracts related to cannabis-adjacent services. |
| ● | Because we serve cannabis-related businesses, we may have difficulty obtaining certain insurance coverages, which could expose us to additional financial liability. |
| ● | The conduct of third parties, including our CRB clients and their financial institution providers, may jeopardize our regulatory compliance and business relationships. |
| ● | Directors, officers, employees, and investors who are not U.S. citizens may face cross-border travel restrictions into the United States due to their involvement in the cannabis industry. |
| ● | We may be subject to marketing and advertising constraints on promoting our services to cannabis-related businesses, which could limit our growth. |
Risks Related to Nasdaq Listing Compliance
| ● | Our Common Stock has previously traded below $1.00 per share, and if it were to trade below $1.00 in the future, it could create an imminent risk of a Nasdaq minimum bid price deficiency notice. |
| ● | A proposed new Nasdaq rule would delist companies whose market capitalization falls below $5 million for 30 or more consecutive trading days. |
| ● | A delisting of our Common Stock could materially impair our ability to make future draws under the ELOC. |
Risks Related to Our Capital Structure and Securities
| ● | The conversion of our Series B Preferred Stock, exercise of Series B Warrants, and future draws under the ELOC could result in substantial dilution to existing holders of our Common Stock. |
| ● | The ELOC is an active financing facility, its pricing and redemption mechanics significantly reduce our net proceeds on each draw and increase dilution to existing stockholders. |
| ● | Our Series B Preferred Stock and Series B Warrants contain anti-dilution and reset provisions that could further dilute common stockholders. |
| ● | Our Common Stock price may be highly volatile, and stockholders may not be able to sell their shares at or above their purchase price. |
| ● | The soundness of our financial institution customers and partners could adversely affect us. |
| ● | Our investment in preferred securities of ADTX is illiquid, subject to impairment, and may result in a partial or total loss. |
Risks Related to Internal Controls and Financial Reporting
| ● | The Second Amended CAA introduces significant new accounting complexity that involves material judgment and estimation uncertainty. |
| ● | One material weakness in revenue recognition related to our activity fee income from deposits held at PCCU has been remediated, however sufficient time has not passed for us to conclude that its is operating effectively. |
| ● | We have identified a material weakness in internal control over financial reporting related to our loan documentation and expected credit loss estimation process, which could result in a material misstatement of our financial statements |
Risks Related to Legal Proceedings and Regulatory Compliance
| ● | An adverse outcome in litigation to which we are or may become a party could materially and adversely affect us. |
| ● | Changes in laws, regulations, or rules applicable to cannabis banking, financial services, or public company reporting could adversely affect our business and results of operations. |
| ● | An interruption in, or breach of security of, our information systems could adversely affect us. |
| ● | We may suffer uninsured losses or losses in excess of our insurance limits. |
Risks Related to Our Securities
| ● | There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq. |
| ● | The market for our securities has been volatile and may continue to be volatile, which would adversely affect the liquidity and price of our securities. |
| ● | The Company may issue additional shares of common or preferred stock under the Equity Incentive Plan or otherwise, any one of which would dilute the interest of the Company’s stockholders and likely present other risks. |
| ● | Our operating results may fluctuate significantly and could fall below the expectations of securities analysts and investors due to seasonality and other factors, some of which are beyond our control, resulting in a decline in our stock price. |
| ● | If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding our Common Stock adversely, then the price and trading volume of the Common Stock could decline. |
| ● | We may be unable to obtain additional financing to fund our operations and growth. |
| ● | Anti-takeover provisions contained in our Second Amended and Restated Certificate of Incorporation and Bylaws, as well as provisions of Delaware law, could impair a takeover attempt, which could limit the price investors might be willing to pay in the future for our Common Stock. |
| ● | Our Second Amended and Restated Certificate of Incorporation provides that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholder’s ability to obtain a favorable judicial forum for disputes with us or our directors, officers, employees or stockholders. |
| ● | The JOBS Act permits “emerging growth companies” like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies. |
| ● | The Certificate of Designation governing our Series B Preferred Stock contains covenants that may limit our business flexibility. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.